CervoMed (CRVO) Share-based Compensation (2010 - 2026)
CervoMed (CRVO) reported Share-based Compensation of $362,275 for Q2 2026, down 27.1% from $497,015 a year earlier but up 3.7% from the prior quarter.
Powered by 
Analysis
CervoMed (CRVO) Share-based Compensation (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, CervoMed's Share-based Compensation came in at $1.3 million, down 11.3% year-over-year; for FY2025, it was $1.45 million, up 3.1% from FY2024.
- Share-based Compensation has increased for three consecutive years, with a five-year compound annual growth rate of 14.5% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $1.41 million in FY2024 (+244.9%), $407,632 in FY2023 (+22.1%), $333,835 in FY2022 (-62.8%) and $897,260 in FY2021 (+21.9%).
- Five-year quarterly Share-based Compensation spans a low of -$303,414 in Q3 2022 and a high of $578,581 in Q2 2024.
- Year over year, Share-based Compensation has now declined in each of the last three quarters, with growth averaging 33.8% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q2 2024 (growth of 829.4%); the low point was Q2 2023 (a decline of 77.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $349,196 (Q1 2026), $298,735 (Q4 2025) and $291,717 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 362.00 Mn |
| 10 | CervoMed | 14.36 Mn | -71.66 Mn | - | 362,275.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 362,275.00 |
| Mar 31, 2026 | 349,196.00 |
| Dec 31, 2025 | 298,735.00 |
| Sep 30, 2025 | 291,717.00 |
| Jun 30, 2025 | 497,015.00 |
| Mar 31, 2025 | 361,167.00 |
| Dec 31, 2024 | 337,711.00 |
| Sep 30, 2024 | 271,215.00 |
| Jun 30, 2024 | 578,581.00 |
| Mar 31, 2024 | 218,215.00 |
| Dec 31, 2023 | 164,972.00 |
| Sep 30, 2023 | 109,168.00 |
| Jun 30, 2023 | 62,252.00 |
| Mar 31, 2023 | 71,240.00 |
| Dec 31, 2022 | 80,988.00 |
| Sep 30, 2022 | 82,384.00 |
| Jun 30, 2022 | 278,130.00 |
| Mar 31, 2022 | 278,131.00 |
| Dec 31, 2021 | 254,308.00 |
| Sep 30, 2021 | 164,392.00 |
API Access
CervoMed Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CRVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CRVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CRVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();